Company Filing History:
Years Active: 2024
Title: Jörg Haupenthal: Innovator in Pharmaceutical Research
Introduction
Jörg Haupenthal is a notable inventor based in Braunschweig, Germany. He has made significant contributions to the field of pharmaceutical research, particularly in the development of compounds that target bacterial infections. His work is characterized by a commitment to innovation and a focus on practical applications in medicine.
Latest Patents
Haupenthal holds a patent for "PqsR inverse agonists." This invention relates to a compound that acts as an inhibitor of PqsR, which is the only known receptor for the Quinolone Signal (PQS). The patent includes a pharmaceutical composition containing one or more of the compounds, as well as a combination preparation that includes at least one compound of the invention and another active pharmaceutical ingredient. The uses of these compounds extend to their application as medicaments, particularly in the treatment or prophylaxis of bacterial infections.
Career Highlights
Haupenthal is associated with Helmholtz-Zentrum für Infektionsforschung GmbH, where he engages in cutting-edge research aimed at combating infectious diseases. His work has been instrumental in advancing the understanding of bacterial signaling and the development of new therapeutic strategies.
Collaborations
Throughout his career, Haupenthal has collaborated with esteemed colleagues, including Ahmed S A Ahmed and Martin Empting. These partnerships have fostered a collaborative environment that enhances the research output and innovation in the field.
Conclusion
Jörg Haupenthal's contributions to pharmaceutical research, particularly through his patent on PqsR inverse agonists, highlight his role as an innovator in the fight against bacterial infections. His work continues to influence the development of new therapeutic approaches in medicine.